At a Glance

Who Are We?

Over the last few years, we have emerged as India’s largest animal health company with presence in 100+ countries.

Our logotype is inspired by nature and its different forms and shapes -from a microscopic view of the skin texture to footprint of a chosen animal. The circular shape evokes the idea of protection and control. It’s a closed and perfect shape that is naturally balanced, reminiscing the brand idea “Animals’ Source of Health”. Pronounced A-lee-vee-rah,  the name is a variant of two Latin words Elvira, word for ‘white, pure, clean’ and Alleviare, word for ‘relief’. It speaks about our commitment to improving animals’ life and well-being at every stage. We are Alivira! Our focus on R&D is taking us even further, and we are committed to applying cutting-edge resources to improve health and well-being at every stage of animals’ lives. All along our processes, we are committed to quality, but moreover, we are committed to safety. That is our guarantee for effective medicines.

Our Philosophy

Our Vision

To be a leading integrated animal health company committed to quality veterinary solutions globally

Our Mission

To deliver quality products competitively while adhering to high standard of quality, governance & compliance

Our Values

Our Values aren't just a collection of words, but the essence of our culture

Our Journey

2013

September

Fomation of Alivira Animal Health Limited

2014

March

Started building multiproduct API facility at Vizag

2014

November

Strengthened our Large Animal portfolio through majority stakes in Provet

2015

October

Strengthened foothold in India through acquisition of Lyka Animal Health

2015

December

Strengthened our distribution in Europe through acquisition of two distribution companies N-Vet and Fendigo

2016

August

Entry in LATAM through majority stake acquisition in Evance, Brazil

2016

August

Entry in Europe through majority stake acquisition in Karizoo, Spain

2017

May

Alivira’s dedicated animal health API facility gets USFDA approval

2017

October

Divestment of human API business

2018

April

Acquired Bremer Pharma in Germany to boost injectable pipeline in EU

2022

February

Strengthened portfolio by the acquistion of companion animals focussed company Nourrie, Brazil